Glaukos Corp. (GKOS)
163.75
+0.58
(+0.36%)
USD |
NYSE |
Oct 02, 16:00
163.76
+0.02
(+0.01%)
Pre-Market: 20:00
Glaukos EPS Diluted (Quarterly) : -0.3124 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3124 |
| March 31, 2026 | -0.341 |
| December 31, 2025 | -2.324 |
| September 30, 2025 | -0.2828 |
| June 30, 2025 | -0.3436 |
| March 31, 2025 | -0.3204 |
| December 31, 2024 | -0.6041 |
| September 30, 2024 | -0.389 |
| June 30, 2024 | -0.9966 |
| March 31, 2024 | -0.8237 |
| December 31, 2023 | -0.7525 |
| September 30, 2023 | -0.6254 |
| June 30, 2023 | -0.6796 |
| March 31, 2023 | -0.7232 |
| December 31, 2022 | -0.659 |
| September 30, 2022 | -0.5792 |
| June 30, 2022 | -0.9616 |
| March 31, 2022 | 0.1086 |
| December 31, 2021 | -0.4661 |
| September 30, 2021 | 0.1263 |
| June 30, 2021 | -0.3775 |
| March 31, 2021 | -0.3603 |
| December 31, 2020 | -0.2363 |
| September 30, 2020 | -0.3523 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.8998 |
| March 31, 2020 | -1.235 |
| December 31, 2019 | 0.8436 |
| September 30, 2019 | -0.3667 |
| June 30, 2019 | -0.173 |
| March 31, 2019 | -0.0371 |
| December 31, 2018 | 0.045 |
| September 30, 2018 | -0.1863 |
| June 30, 2018 | -0.15 |
| March 31, 2018 | -0.08 |
| December 31, 2017 | 0.03 |
| September 30, 2017 | 0.04 |
| June 30, 2017 | -0.10 |
| March 31, 2017 | 0.02 |
| December 31, 2016 | 0.0036 |
| September 30, 2016 | 0.03 |
| June 30, 2016 | 0.06 |
| March 31, 2016 | 0.03 |
| December 31, 2015 | -0.07 |
| September 30, 2015 | -0.07 |
| June 30, 2015 | -10.96 |
| March 31, 2015 | -0.0309 |
| March 31, 2014 | -0.1266 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 1.103 |
| Abbott Laboratories | 0.5324 |
| Alphatec Holdings, Inc. | -0.1647 |
| Artivion, Inc. | -0.278 |
| Insulet Corp. | 1.066 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.38M |
| Revenue (Quarterly) | 185.61M |
| Total Expenses (Quarterly) | 203.99M |
| Enterprise Value | 9.455B |
| Gross Profit Margin (Quarterly) | 81.67% |
| Profit Margin (Quarterly) | -9.90% |
| Earnings Yield | -1.99% |
| Normalized Earnings Yield | -1.141 |